NCT06205082View on ClinicalTrials.gov

A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

81

Participants

Timeline

Start Date

October 14, 2023

Primary Completion Date

October 30, 2025

Study Completion Date

June 30, 2026

Conditions

Advanced Solid Tumor

Interventions

DRUG

LIT-00814

LIT-00814 is an oral tablet.

Trial Locations (1)

100000

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

LittDD Medicines Ltd

INDUSTRY